Sinsin Pharmaceutical Co. Ltd (002800) — Cash Flow Reinvestment Rate
Sinsin Pharmaceutical Co. Ltd (002800) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting ₩972.34 Million (capex ₩871.54 Million plus investments ₩-100.80 Million) from operating cash flow of ₩4.70 Billion. Check 002800 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sinsin Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2015–2024)
Historical reinvestment intensity for Sinsin Pharmaceutical Co. Ltd across 9 annual periods. Explore 002800 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Sinsin Pharmaceutical Co. Ltd (2015–2024)
Year-by-year capital reinvestment analysis for Sinsin Pharmaceutical Co. Ltd. For live market cap and broader valuation context, see Sinsin Pharmaceutical Co. Ltd market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.19x | ₩7.07 Billion | ₩5.94 Billion | ₩1.51 Billion | ▼ -57.8% |
| 2023 | 2.82x | ₩11.08 Billion | ₩3.93 Billion | ₩5.03 Billion | ▲ +1320.4% |
| 2022 | 0.20x | ₩1.08 Billion | ₩5.46 Billion | ₩907.13 Million | ▼ -99.8% |
| 2021 | 115.84x | ₩2.69 Billion | ₩23.18 Million | ₩2.68 Billion | ▲ +1363.9% |
| 2020 | 7.91x | ₩14.76 Billion | ₩1.87 Billion | ₩11.97 Billion | ▼ -75.9% |
| 2018 | 32.86x | ₩25.44 Billion | ₩774.24 Million | ₩25.44 Billion | ▲ +4099.6% |
| 2017 | 0.78x | ₩3.57 Billion | ₩4.57 Billion | ₩3.57 Billion | ▼ -70.8% |
| 2016 | 2.68x | ₩7.48 Billion | ₩2.79 Billion | ₩7.43 Billion | ▲ +168.4% |
| 2015 | 1.00x | ₩5.22 Billion | ₩5.24 Billion | ₩5.22 Billion | — |